Plunkett Research Online: Regeneron Pharmaceuticals Inc

REGENERON PHARMACEUTICALS INC (REGN:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL .....



Regeneron Pharmaceuticals Inc
Ticker: REGN
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 914 847-7000
Fax:
Address: 777 Old Saw Mill River Road
Tarrytown, NY 10591-6707 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Drugs-Diversified
Protein-Based Drugs
Small-Molecule Drugs
Genetics & Transgenic Mouse Technologies
Contacts Description
Leonard SchleiferCEO/Co-Chairman of the Board/Co-Founder/Co-President/Director
Robert LandryCFO/Executive VP, Divisional
See More
Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products, including Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL .....See More See More

Auditor: PricewaterhouseCoopers LLP
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202220212020201920182017
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
Arcalyst
Praluent
EYLEA
Dupixent
ZALTRAP
VelociGene
VelociMouse
VelocImmune
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: